| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2009 | WO2009067697A1 Therapeutic compounds |
| 05/28/2009 | WO2009067692A1 Antibacterial aminoglycoside analogs |
| 05/28/2009 | WO2009067690A2 Methods for safe and effective treatment using oxazaphosphorine drugs |
| 05/28/2009 | WO2009067686A2 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
| 05/28/2009 | WO2009067684A1 Modified release niacin formulations |
| 05/28/2009 | WO2009067674A2 Polymorphs of sunitinib base and processes for preparation thereof |
| 05/28/2009 | WO2009067644A1 Compositions, systems and methods for obtaining and expanding insulin-producing cells |
| 05/28/2009 | WO2009067630A1 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/28/2009 | WO2009067618A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067607A2 Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders |
| 05/28/2009 | WO2009067604A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009067586A1 Biaryl substituted diazabicycloalkane derivatives |
| 05/28/2009 | WO2009067579A1 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
| 05/28/2009 | WO2009067557A1 Deferasirox pharmaceutical compositions |
| 05/28/2009 | WO2009067547A1 Polo-like kinase inhibitors |
| 05/28/2009 | WO2009067543A2 Treatment of histone deacetylase mediated disorders |
| 05/28/2009 | WO2009067541A2 Integrase inhibitors |
| 05/28/2009 | WO2009067535A1 Topical composition for treating pain |
| 05/28/2009 | WO2009067530A1 Increased protein or energy digestion resulting from inclusion of metal amino acid chelates in animal feed |
| 05/28/2009 | WO2009067500A1 Administration of an inhibitor of hdac |
| 05/28/2009 | WO2009067453A1 Combinations of hdac inhibitors and proteasome inhibitors |
| 05/28/2009 | WO2009067438A1 Use of trpv1 receptor antagonists for treating dry eye and ocular pain |
| 05/28/2009 | WO2009067410A1 Small-molecule modulators of trp-p8 activity |
| 05/28/2009 | WO2009067409A1 2',4'-substituted nucleosides as antiviral agents |
| 05/28/2009 | WO2009067405A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | WO2009067401A1 Cycloalkyloxy-and hetξrocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | WO2009067397A2 Treatment for solid tumors |
| 05/28/2009 | WO2009067392A1 Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c |
| 05/28/2009 | WO2009067317A2 Use of levocabastine for modulating generation of pro- inflammatory cytokines |
| 05/28/2009 | WO2009067296A1 Treatment of oral pharyngeal dysphagia |
| 05/28/2009 | WO2009067273A1 Pde5 inhibitors for treating pain caused by osteoarthritis |
| 05/28/2009 | WO2009067272A1 Immunoassay for detection and quantification of amyloid-b peptides |
| 05/28/2009 | WO2009067245A2 Compositions and methods for tissue repair |
| 05/28/2009 | WO2009067243A2 Modulation of cd40 expression |
| 05/28/2009 | WO2009067233A1 Beta carbolines and uses thereof |
| 05/28/2009 | WO2009067221A2 Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| 05/28/2009 | WO2009067202A1 Spiropiperidines for use as tryptase inhibitors |
| 05/28/2009 | WO2009067182A2 Phospholipid compositions and uses thereof |
| 05/28/2009 | WO2009067166A2 Non-nucleoside reverse transcriptase inhibitors |
| 05/28/2009 | WO2009067108A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | WO2009067035A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
| 05/28/2009 | WO2009066956A2 Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same |
| 05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 05/28/2009 | WO2009066774A1 Selective expression inhibitor for aurora kinase a and aurora kinase b genes |
| 05/28/2009 | WO2009066773A1 Orally disintegrating tablet |
| 05/28/2009 | WO2009066763A1 Preparation for application to body surface and preparation holding sheet for application to body surface |
| 05/28/2009 | WO2009066752A1 Plastic container having cyclic polyolefin layer |
| 05/28/2009 | WO2009066746A1 Material for preventing tissue adhesion and material for preventing joint contracture |
| 05/28/2009 | WO2009066685A1 Sense-improving agent |
| 05/28/2009 | WO2009066562A1 Differentiation promoter and/or proliferation promoter for erythrocyte stem cells, use of methionine for preventing or treating senile anemia, and compositions containing methionine |
| 05/28/2009 | WO2009066457A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 05/28/2009 | WO2009066325A1 Controlled release pharmaceutical compositions of pregabalin |
| 05/28/2009 | WO2009066301A2 Methods and compositions for treating pdx virus with tellurium-containing compounds |
| 05/28/2009 | WO2009066300A2 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 05/28/2009 | WO2009066299A2 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease |
| 05/28/2009 | WO2009066298A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof |
| 05/28/2009 | WO2009066152A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
| 05/28/2009 | WO2009066138A2 Stabilization of vitamin b complex and lidocaine hydrochloride injection |
| 05/28/2009 | WO2009066117A1 Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
| 05/28/2009 | WO2009066113A1 Improved anti-platelet compositions and methods |
| 05/28/2009 | WO2009066107A1 Use of a nicotinic receptor agonist |
| 05/28/2009 | WO2009066102A1 Vaginal lubricant comprising hyaluronic acid |
| 05/28/2009 | WO2009066085A1 Treatment of heart failure with normal ejection fraction |
| 05/28/2009 | WO2009066084A1 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| 05/28/2009 | WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
| 05/28/2009 | WO2009066069A1 Treatment of protein folding disorders |
| 05/28/2009 | WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use |
| 05/28/2009 | WO2009066021A1 Use of oleocanthal for the treatment of lipid metabolism disorders |
| 05/28/2009 | WO2009066009A1 Novel 4,5-dihydroisoxazoles with estrogenic activity |
| 05/28/2009 | WO2009066008A1 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity |
| 05/28/2009 | WO2009066006A1 Vaginal delivery system |
| 05/28/2009 | WO2009065946A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 05/28/2009 | WO2009065926A2 New anticancer compounds |
| 05/28/2009 | WO2009065910A2 Acid addition salts of imatinib and formulations comprising the same |
| 05/28/2009 | WO2009065893A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same |
| 05/28/2009 | WO2009065854A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/28/2009 | WO2009065850A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/28/2009 | WO2009065846A1 A method for treating addiction |
| 05/28/2009 | WO2009065845A1 A method for treating over-eating disorders |
| 05/28/2009 | WO2009065787A1 Use of amorolfine for treating a nail disease by iontophoresis |
| 05/28/2009 | WO2009065604A2 Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene |
| 05/28/2009 | WO2009065596A2 Use of mnk inhibitors for the treatment of alzheimer's disease |
| 05/28/2009 | WO2009065570A1 Non-peptidic promoters of apoptosis |
| 05/28/2009 | WO2009065503A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/28/2009 | WO2009065472A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/28/2009 | WO2009065395A2 Novel use of omega-3-fatty acid(s) |
| 05/28/2009 | WO2009065298A1 Piperazine derivatives, preparation process and pharmaceutical use thereof |
| 05/28/2009 | WO2009065287A1 Novel mangiferin calcium salts, the method for its preparation and its use |
| 05/28/2009 | WO2009065232A1 Cancer diagnostic and therapeutic methods that target plk4/sak |
| 05/28/2009 | WO2009065226A1 Modulation of tdag51 to inhibit scar formation in skin wound healing and internal organ fibrosis |
| 05/28/2009 | WO2009065193A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses |
| 05/28/2009 | WO2009065169A1 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2009049098A3 Materials and methods for regulating the activity of phosphatases |
| 05/28/2009 | WO2009047723A3 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 05/28/2009 | WO2009047644A3 Method of treating vitamin d insufficiency and deficiency |
| 05/28/2009 | WO2009047534A3 Fused phenothiazinium compounds, preparation method thereof and use as photoantimicrobials |
| 05/28/2009 | WO2009045908A3 A method for screening of prostaglandin compounds comprising an optimal formulation for the enhancement of hair growth and the stimulation of follicular anagen and formulations resulting therefrom |